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Abstract. Diet is important in triggering the symptoms of 
irritable bowel syndrome (IBS). This study investigated the 
impact of dietary guidance on the symptoms, quality of life 
and habitual diet of patients with IBS. Forty-six patients who 
IXOÀOOHGWKH5RPH,,,FULWHULDIRUWKHGLDJQRVLVRI,%6ZHUH
included. Of these patients, 17 completed the entire study. 
Each patient attended three sessions (~45 min in duration) and 
received individual guidance on their dietary management. 
The patients were asked to complete the following question-
naires prior to receiving the dietary guidance, and at least 
3 months subsequently: The Birmingham IBS symptom score 
questionnaire, the IBS Quality of Life (IBS-QOL) question-
naire, the Short-Form Nepean and Dyspepsia Index (SF-NDI) 
and the MoBa Food Frequency Questionnaire (MoBa FFQ). 
The time at which patients completed the questionnaires 
following dietary guidance ranged from 3-9 months (median, 
4 months). The total IBS symptom scores were reduced once 
the patients had received dietary guidance (P=0.001). The 
total score for the quality of life, as assessed by the IBS-QOL 
DQGWKH6)1',LQFUHDVHGVLJQLÀFDQWO\IROORZLQJWKHGLHWDU\
guidance sessions (P=0.003 and P=0.002, respectively). 
There were no statistical differences in the intake of calories, 
FDUERK\GUDWHÀEHUSURWHLQIDWRUDOFRKROLQWKHSDWLHQWVZLWK
IBS following dietary guidance. There were increases in the 
consumption of dairy products, ơ-carotene, retinol equivalents, 
ULERÁDYLQYLWDPLQ%12 and calcium, although only the increase 
in vitamin B12FRQVXPSWLRQZDVVWDWLVWLFDOO\VLJQLÀFDQW7KHUH
ZDVDVLJQLÀFDQWUHGXFWLRQLQWKHFRQVXPSWLRQRIFHUWDLQIUXLWV
and vegetables that were rich in highly fermentable short-chain 
carbohydrates, disaccharides, monosaccharides and polyols, as 
ZHOODVLQVROXEOHÀEHUV,QFRQFOXVLRQWKUHHPLQGLHWDU\
guidance sessions, administered by a nurse, reduced the symp-
toms and improved the quality of life of patients with IBS, 
and resulted in an adequate intake of vitamins and minerals. 
Individual dietary guidance is a cost-effective option for the 
management of IBS.
Introduction
Irritable bowel syndrome (IBS) is a chronic functional bowel 
disorder characterized by a combination of symptoms that have 
a considerable impact on the patient's quality of life. These 
symptoms include abdominal pain or discomfort and altered 
bowel habits (1,2). IBS is more common in females than in 
males, and is diagnosed more frequently in patients under the 
age of 50 (1). The prevalence of IBS has been calculated to 
range from 5-15% of the population worldwide, as determined 
by diagnostic criteria, such as the Rome criteria (1-14).
Approximately two-thirds of patients with IBS consider 
their symptoms to be related to their diet (15) and therefore 
restrict their intake of certain dietary agents that they perceive 
to be provocative. The most commonly reported triggers are 
carbohydrates and fatty foods, milk and dairy products, wheat 
products, caffeine, hot spices, certain meats, cabbage, onions, 
peas, beans and fried and smoked foods (16-19). Despite 
these reported effects, numerous studies have demonstrated 
that dietary composition does not markedly differ between 
patients with IBS and controls (15-21), although patients with 
IBS appear to have a low intake of calcium, potassium, magne-
sium, vitamin A, vitamin B12DQGULERÁDYLQ
In a previous study by our group, dietary guidance 
administered individually to patients with IBS reduced the 
symptoms of the condition and improved their quality of life, 
in addition to affecting their habitual diet so that their intake 
of minerals and vitamins became normalized (18). However, 
two groups of patients with IBS were compared in the study; 
one group received individual dietary guidance, whilst the 
second did not receive any dietary guidance. There were 
several important factors in the investigation that may have 
affected the outcome of the study, but were not able to be 
excluded, such as the differences in gender distribution and 
social background between the two groups. The present inves-
tigation was designed to control for these factors, and studied 
the effects in the same individuals before and 3-9 months 
after receiving individual dietary guidance.
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Material and methods
Patients. Patients who had been referred to the gastroenter-
ology department of Stord Helse-Fonna Hospital (Stord, 
Norway), and who fulfilled the Rome III criteria for the 
diagnosis of IBS were considered for inclusion in the study. 
Although both genders were able to participate, the patients 
were required to be between 18 and 69 years of age. Exclusion 
criteria comprised the presence of organic gastrointestinal 
GLVHDVHFOLQLFDOO\VLJQLÀFDQWV\VWHPLFGLVHDVHVSUHJQDQF\
or lactation, drug abuse, serious psychiatric diseases and 
collaboration issues. In addition, with the exception of appen-
dectomy, cesarean section and hysterectomy, patients who had 
undergone abdominal surgery were excluded. This study was 
performed in accordance with the Declaration of Helsinki and 
was approved by the Regional Committee for Medical and 
Health Research Ethics West, Bergen, Norway. All patients 
provided oral and written consent to participate. 
Study design. In total, 46 patients were included in the study. 
This included 35 females and 11 males with a mean age of 
35 years (range, 18-69 years). Of these, 21 reported diarrhea 
(IBS-D), 18 reported constipation (IBS-C) and seven reported 
a mixture of both symptoms (IBS-M) as the predominant 
symptom of IBS. The patients underwent a complete physical 
examination, a gastroscopy with duodenal biopsies, a colo-
noscopy with segmental biopsies and several blood tests 
to exclude other organic causes for their symptoms. Each 
patient received three sessions of individual guidance on 
GLHWDU\PDQDJHPHQWIURPDUHJLVWHUHGQXUVHZLWKDVSHFLÀF
education in IBS diet, with each session lasting ~45 min. The 
patients were asked to complete the following questionnaires 
before and 3 months subsequent to receiving the dietary 
guidance: The Birmingham IBS symptom score question-
naire, the IBS-Quality of Life (IBS-QOL) questionnaire, the 
Norwegian version of the Short-Form Nepean and Dyspepsia 
Index (SF-NDI) questionnaire and the MoBa Food Frequency 
Questionnaire (MoBa FFQ).
Individual guidance on diet management. Each patient 
attended three 45 min sessions with a registered nurse with 
special training in the IBS diet, and seven years experience of 
providing dietary guidance to patients with IBS. The sessions 
were scheduled with intervals of 2 weeks between them. The 
information at the sessions was provided orally, and using 
charts and illustrative drawings. Written information was also 
supplied.
In the first session, the patient received general infor-
mation with regard to the importance of regular meals and 
healthy eating habits, along with the effect of the diet on the 
development of symptoms. Emphasis was placed on the role 
of poorly absorbed, highly fermentable oligosaccharides, 
disaccharides, monosaccharides and polyols (FODMAPs), 
although patients were also informed of the effects of soluble 
DQGLQVROXEOHGLHWDU\ÀEHUV,WZDVHPSKDVL]HGWKDWPLONDQG
dairy products were not triggers for IBS symptoms, and that 
the patients should consume dairy products daily. The patient 
was asked to keep a diary in which they recorded the time of 
eating/drinking, and the types of food and drinks they ingested 
daily. In addition, they were asked to report the occurrence 
of abdominal pain, abdominal distention and bloating, as 
well as stool frequency and consistency. The patients were 
instructed to try protein-, fat-, and carbohydrate-rich/poor 
diets and report the symptoms for each in the diary. This was 
performed over a 2-week period. 
In the second scheduled session, the information provided 
in the first session was summarized, before the diary was 
examined to determine which food items may be triggering 
the patient's symptoms. The patients were then advised to 
avoid these items and other items that were rich in FODMAPs 
DQGLQVROXEOHÀEHUVVXFKDVRQLRQVJDUOLFSDSULNDFDEEDJH
carbonated beverages, ‘lite’ products (those containing arti-
ÀFLDOVZHHWHQHUVEDQDQDVEHDQVDQGSHDV7KHSDWLHQWZDV
asked to replace wheat and wheat products with spelt and 
spelt products, respectively, and was provided with a list of 
vegetables and fruits that contained lower levels of FODMAPs 
DQGLQVROXEOHÀEHUV7KHSDWLHQWVZHUHDOVRLQVWUXFWHGWR
avoid the intake of food items supplemented with probiotics 
during the course of the study.
'XULQJWKHWKLUGDQGÀQDOVHVVLRQWKHSDWLHQW
VH[SHUL-
ence regarding the management of their diet was discussed 
with the nurse, so that the patient and nurse were then able to 
utilize this information to design a suitable diet for the patient 
to follow.
IBS symptom assessment. The Birmingham IBS symptom 
score questionnaire was developed to measure the symptoms 
of patients with IBS. It is disease-specific, acceptable to 
patients and suitable for self-completion. Its dimensions have 
been demonstrated to have good reliability, external validity 
and sensitivity (22). The Birmingham IBS symptom score 
questionnaire consists of 11 questions based on the frequency 
of IBS symptoms. The responses to the questions are measured 
on a six-point Likert scale, ranging from 0 (none of the time) 
to 5 (all of the time). The questionnaire has three underlying 
GLPHQVLRQVSDLQWKUHHLWHPVGLDUUKHDÀYHLWHPVDQGFRQVWL-
pation (three items), with lower scores indicating improved 
symptoms.
Assessment of quality of life. The quality of life in patients with 
IBS was assessed by the IBS-QOL and SF-NDI questionnaires.
The IBS-QOL questionnaire is a 34-item, IBS-specific 
quality of life measure that assesses physical and psychoso-
cial functioning as a result of IBS (23,24). The questionnaire 
comprises eight domains; dysphoria, interference with activity, 
body image, health concerns, food avoidance, social reac-
tion, sexual function and impact on relations. Responses are 
SURYLGHGRQWKHIROORZLQJÀYHSRLQW/LNHUWVFDOHQRWDWDOO
slightly, moderately, quite a lot and extremely.
7KH6)1',TXHVWLRQQDLUHLVDGLVHDVHVSHFLÀFPHDVXUHRI
the health-related quality of life (HRQoL), with 10 questions 
GLYLGHGLQWRÀYHVXEVFDOHVFRUHVWHQVLRQLQWHUIHUHQFHZLWK
daily activities, disruption to regular eating/drinking, knowl-
edge towards/control over disease symptoms and interference 
with work/VWXG\(DFKTXHVWLRQKDVÀYHRSWLRQVUDQJLQJIURP
1 (not at all) to 5 (extremely); thus, the total score ranges from 
10-50, as per the developer's original calculation formula, 
with higher scores indicating worse functioning or symptoms. 
This questionnaire was constructed and validated primarily in 
patients with dyspepsia (25). A Norwegian translation of the 
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Figure 1. (A) Total score and scores on the three dimensions [(B) abdominal pain, (C) diarrhea and (D) constipation] of the Birmingham irritable bowel 
syndrome (IBS) symptom score questionnaire in patients with IBS before and following dietary guidance sessions. *P<0.05 and **P<0.01. 
Figure 2. Total score for quality of life in patients with irritable bowel syn-
drome (IBS) before and following dietary guidance sessions, as assessed by 
the Irritable Bowel Syndrome-Quality of Life (IBS-QOL) questionnaire. 
**P<0.01.
Table I. Scores on the eight domains of the Irritable Bowel Syndrome-Quality of Life (IBS-QOL) questionnaire in patients with 
IBS before and following dietary guidance sessions.
 IBS-QOL score  
 ----------------------------------------------------------------------------------------------------------------------------- 
Domain Before dietary guidance Following dietary guidance P-value
Dysphoria 28.1±1.4 31.5±0.9 0.009b
Interference with activity 18.6±0.7 20.9±0.7 0.003b
Body image 18.1±0.8 20.0±1.1 0.007b
Health worry 15.2±0.7 16.9±0.6 0.001b
Food avoidance 5.8±0.6 4.6±0.4 0.018b
Social reactions 18.8±0.8 20.6±0.7 0.021a
Sexual function 8.2±0.4 8.9±0.3 0.035a
Impact on relations 12.8±0.4 13.4±0.4 0.172
Data are presented as the mean ± SEM. aP<0.05 and bP<0.01.
Figure 3. Total score for the reduction in quality of life, as detected by the 
Short-Form Nepean and Dyspepsia Index (SF-NDI) quality of life question-
naire. **P<0.01. 
  A   B
  C   D
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questionnaire was validated and demonstrated to perform well 
in patients with IBS (26). 
Dietary assessment. Dietary intake was assessed using a 
semi-quantitative, self-administered food frequency question-
naire (MoBa FFQ). The MoBa FFQ asks participants to report 
the frequency of consumption and portion size of certain items 
RYHUDGHÀQHGSHULRGRIWLPH(DFKLWHPLVGHÀQHGE\DVHULHVRI
foods or beverages. Additional questions on food purchasing 
and preparation methods enable the analysis software to 
IXUWKHUUHÀQHQXWULHQWFDOFXODWLRQV7KH0R%D))4XVHGLQ
this study was developed and validated by the Norwegian 
Institute of Public Health in Oslo, Norway (27,28). It enquires 
about the intake of 225 food items, grouped according to 
typical Norwegian meal patterns, and is designed to capture 
WKHGLHWDU\KDELWVRIWKHSDUWLFLSDQWRYHUDGHÀQHGSHULRG
including the intake of any oral supplements. Analysis of the 
obtained data provides information concerning the intake of 
energy, water, macronutrients, micronutrients, minerals and 
DOFRKROLQDGGLWLRQWRVSHFLÀFIRRGJURXSVDQGLWHPV,W
also yields information regarding meal patterns.
Statistical analysis. The paired t-test was used to analyze the 
data. The data are presented as the mean ± SEM values, and 
3ZDVFRQVLGHUHGWRLQGLFDWHDVWDWLVWLFDOO\VLJQLÀFDQW
difference.
Table II. Daily intake of macronutrients and alcohol in patients with irritable bowel syndrome (IBS) before and following dietary 
guidance sessions.
 Before dietary guidance Following dietary guidance P-value
Energy (kcal) 1968±183 1889±219 0.610
Carbohydrates (g)   
  Total 249.7±28.6 228.3±30.0 0.342
  Starch 125.8±15.5 108.2±13.1 0.185
Fiber (g) 27.4±2.5 23.1±2.2 0.093
Protein (g) 75.7±5.5 78.2±9.4 0.704
Fats (g)   
  Total 72.5±6.3 72.3±7.6 0.967
  Saturated 26.6±2.6 26.5±3.2 0.965
  Cholesterol 232.6±26.0 288.6±38.9 0.040a
  Trans 1.4±0.2 1.8±0.4 0.243
  Monounsaturated 24.2±2.1 24.4±2.4 0.918
  Polyunsaturated 14.9±1.4 13.9±1.3 0.334
Sugar (g) 50.4±8.3 49.4±9.2 0.876
Alcohol (ml) 1.4±0.6 1.2±0.4 0.620
Data are presented as the mean ± SEM. aP<0.05.
Table III. Weekly pattern of meal types in patients with irritable bowel syndrome (IBS) before and following dietary guidance 
sessions.
  Number of meals
 --------------------------------------------------------------------------------------------------------------------------------  
Meal type Before dietary guidance Following dietary guidance P-value
Breakfast 2.1±0.5 1.8±0.4 0.260
Morning snack 5.4±0.6 4.4±0.5 0.256
Lunch 3.9±0.6 3.0±0.5 0.219
Snack before dinner 6.2±0.6 5.9±0.6 0.716
Dinner 1.4±0.2 1.3±0.2 0.579
Evening snack 5.6±0.6 6.2±0.5 0.370
Supper 3.1±0.5 3.2±0.4 0.675
Night time meal 7.4±0.5 7.2±0.5 0.867
Data are presented as the mean ± SEM.
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Results
Patients. Of the 46 patients recruited to this study, 18 aban-
doned the study; one was excluded due to non-compliance and 
one due to cooperation problems; four became better following 
the dietary guidance sessions, and then lost interest in and 
motivation for completing the study; two were diagnosed with 
celiac disease; one was diagnosed with lupus; one became 
pregnant and one moved abroad during the study. Thus, 17 
of the original 46 patient cohort completed the study. These 
7DEOH,9'DLO\LQWDNHRIGDLU\SURGXFWVDUWLÀFLDOVZHHWHQHUVDQGVRIWGULQNVLQSDWLHQWVZLWKLUULWDEOHERZHOV\QGURPH,%6
before and following dietary guidance sessions.
Dairy products Before dietary guidance Following dietary guidance P-value
Milk products, whole fat (g) 0.8±0.5 6.2±5.0 0.262
Milk products, low fat (g) 118.8±59.9 138.7±82.8 0.506
Sour milk with probiotic supplement (g) 31.5±29.3 4.5±2.6 0.339
Yoghurt (g) 14.1±4.6 34.4±10.6 0.070
Soya milk (g) 0.9±0.6 1.3±0.9 0.332
Cheese, whole fat (g) 7.0±2.9 7.8±3.7 0.676
Cheese, low fat (g) 0.2±0.1 0.4±0.2 0.260
Brown goat's cheese (g) 1.1±0.4 2.6±1.8 0.335
$UWLÀFLDOVZHHWHQHUVPJ   
Soft drinks, sweetened (ml) 71.3±31.9 53.5±20.7 0.478
Soft drinks, unsweetened (ml) 91.7±39.8 37.5±29.2 0.085
Data are presented as the mean ± SEM.
Table V. Daily intake of vitamins and minerals in patients with irritable bowel syndrome (IBS) before and following dietary 
guidance sessions.
 Before dietary guidance Following dietary guidance P-value
Vitamins   
  ơ-carotene (mg) 2543±511 2721±360 0.624
  Folate (μg) 224.8±17.8 223.2±28.8 0.942
  Niacin equivalents (μg) 28.3±2.0 29.5±3.1 0.584
  Retinol equivalents (mg) 839±95 1039±152 0.199
5LERÁDYLQPJ   
  Thiamin (mg) 1.3±0.1 1.2±0.2 0.727
  Vitamin B6 (mg) 1.4±0.1 1.3±0.1 0.478
  Vitamin B12 (μg) 4.5±0.5 6.1±1.1 0.042
a
  Vitamin C (mg) 124.6±18.3 126.1±16.6 0.913
  Vitamin D (μg) 2.9±0.4 3.8±0.5 0.079
  Vitamin E (mg) 10.2±0.9 10.1±0.9 0.941
Minerals   
  Calcium (mg) 773±85 884±186 0.373
  Copper (mg) 1.2±0.1 1.1±0.1 0.383
  Iron (mg) 9.7±0.7 8.9±0.9 0.412
  Magnesium (mg) 358±28.3 333.5±42.8 0.500
  Phosphorus (mg) 1455±110 1475±213 0.901
  Potassium (mg) 3577±281 3454±400 0.686
  Selenium (μg) 50.1±3.7 54.6±5.9 0.316
  Sodium (mg) 2694±209 2618±276 0.754
  Zinc (mg) 9.6±0.7 9.5±1.2 0.925
Data are presented as the mean ± SEM. aP<0.05.
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Table VI. Daily intake of various vegetables, fruits and berries in patients with irritable bowel syndrome (IBS) before and 
following dietary guidance sessions.
 Daily intake (g)
 --------------------------------------------------------------------------------------------------------------------------
Vegetables/fruits/berries Before dietary guidance Following dietary guidance P-value
&DXOLÁRZHUUDZ   
&DXOLÁRZHUFRRNHG   
Broccoli: raw 1.5±1.0 1.2±1.0 0.821
Broccoli: cooked 5.2±1.4 5.4±2.2 0.909
Peas 2.1±0.5 0.4±0.2 0.006b
Cabbage: raw 1.5±1.0 0.1±0.1 0.193
Cabbage: cooked 2.3±0.7 0.2±0.2 0.010a
Paprika: raw 4.9±1.4 1.8±1.3 0.006b
Paprika: cooked 3.3±0.9 0.7±0.3 0.019a
Onion, leak or garlic 11.5±2.9 1.7±0.8 0.003b
Tomatoes 5.7±1.6 11.2±3.4 0.102
Potatoes: fried 5.5±1.2 7.6±1.3 0.070
Potatoes: cooked, mashed or gratin 63.7±9.8 61.1±8.5 0.770
Oranges 44.5±17.4 47.5±17.2 0.884
Bananas 24.1±8.0 4.7±1.6 0.023a
Grapes 16.2±5.0 2.6±1.4 0.016a
Pears 16.5±6.3 4.5±2.4 0.059
Apples 29.3±8.0 34.7±13.6 0.688
Peaches 8.9±3.2 6.7±3.1 0.553
Grapefruit 1.4±0.9 0.6±0.3 0.421
Mangos 4.3±2.1 4.9±3.3 0.885
Plums 2.3±0.9 4.4±2.9 0.497
Melons 4.9±1.4 4.5±1.7 0.692
Blueberries 6.9±2.1 6.5±2.1 0.879
Strawberries 12.2±3.0 12.2±5.1 0.992
Prunes: dried 0.3±0.1 0.7±0.3 0.188
Apricots: dried 0.5±0.3 0.9±0.4 0.329
Mushrooms 1.7±0.3 1.4±0.4 0.513
Green beans 0.3±0.2 0.3±0.2 1.000
Data are presented as the mean ± SEM. aP<0.05 and bP<0.01.
Table VII. Daily intake of patients with irritable bowel syndrome (IBS), demonstrating the replacement of wheat products with 
spelt products following dietaryguidance sessions.
 Daily intake (g)
 -------------------------------------------------------------------------------------------------------------------------------
Wheat/spelt products Before dietary guidance Following dietary guidance P-value
White bread 3.4±1.7 4.4±1.7 0.636
Dark bread 85.4±27.3 48.0±21.5 0.319
Spaghetti and other pasta 15.1±2.0 13.4±1.6 0.456
:DIÁHVRUSDQFDNHV   
Chocolate cakes 5.1±0.8 2.8±0.7 0.002b
Crisp bread 15.4±7.2 17.2±6.3 0.723
Sweet buns 4.7±1.5 1.1±0.3 0.025a
Data are presented as the mean ± SEM. aP<0.05 and bP<0.01.
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SDWLHQWVFRPSULVHGIHPDOHVDQGÀYHPDOHVZLWKDPHDQDJH
of 34 years (range, 20-45 years); six of the 17 were IBS-D, eight 
were IBS-C and three were IBS-M. The time taken between 
receiving dietary guidance and completing the second set of 
questionnaires ranged from 3-9 months (median, 4 months).
Birmingham IBS symptom score questionnaire. The total 
scores of the Birmingham IBS symptom score questionnaires 
before and subsequent to receiving dietary guidance were 
41.47±1.62 and 35.71±1.12, respectively. The reduction in 
V\PSWRPVZDVVWDWLVWLFDOO\VLJQLÀFDQW3 $OOWKUHHRI
the questionnaire dimensions (i.e., abdominal pain, diarrhea 
and constipation) were also reduced following the dietary 
guidance sessions; however, the result for constipation was not 
VWDWLVWLFDOO\VLJQLÀFDQW)LJ
IBS-QOL. 7KHWRWDO,%642/VFRUHLQFUHDVHGVLJQLÀFDQWO\
from 125.4±4.2 to 136.8±3.8 following the dietary guid-
ance sessions (P=0.003). This improvement was statistically 
VLJQLÀFDQWLQDOOGRPDLQVZLWKWKHH[FHSWLRQRIWKHLPSDFWRQ
relations (Fig. 2 and Table I).
SF-NDI. 7KHWRWDO6)1',VFRUHVZKLFKUHÁHFWWKHUHGXFWLRQ
in HRQoL) before and following the dietary guidance sessions 
were 29.1±2.2 and 20.2±1.5, respectively. This improvement in 
+54R/ZDVVWDWLVWLFDOO\VLJQLÀFDQW3 )LJ
MoBa FFQ. 7KHUHZHUHQRVWDWLVWLFDOO\VLJQLÀFDQWGLIIHUHQFHV
LQWKHLQWDNHRIFDORULHVFDUERK\GUDWHWRWDODQGVWDUFKÀEHU
protein, fat (total, saturated and trans-, mono- and polyunsatu-
rated), sugar or alcohol in the patients with IBS who received 
GLHWDU\JXLGDQFH7DEOH,,+RZHYHUWKHUHZDVDVLJQLÀFDQW
increase in the intake of cholesterol. The dietary guidance did 
not affect the meal pattern in the patients with IBS (Table III). 
There was an increase in the consumption of various dairy 
SURGXFWVDOWKRXJKWKHFKDQJHZDVQRWVWDWLVWLFDOO\VLJQLÀFDQW
(Table IV). However, there was a decrease in the consump-
tion of dairy products with probiotic supplements, in line with 
our recommendation during the study. Although the intake 
of ơFDURWHQHUHWLQROHTXLYDOHQWVFDOFLXPDQGULERÁDYLQZDV
increased, only the increase in vitamin B12 was statistically 
VLJQLÀFDQW7DEOH97KHUHZDVDVLJQLÀFDQWUHGXFWLRQLQWKH
FRQVXPSWLRQRIYDULRXV)2'0$3DQGLQVROXEOHÀEHUULFK 
fruits and vegetables (Table VI). The replacement of wheat 
and wheat products with spelt and spelt products, respectively, 
enabled the patients to consume the food items that they 
considered essential (Table VII).
Discussion
There was a high incompletion rate in this study, with a comple-
tion rate of only 37%, and a rate of abandonment of 39%. This 
was within the limits (30-40%) of comparative studies (18,29). 
The low number of patients completing the study was due to 
several factors; 4% due to non-compliance and collaboration 
problems leading to exclusion; 9% due to a marked improve-
ment in symptoms following the dietary guidance leading to 
a lack of motivation to continue with the study; 7% due to the 
diagnosis of an organic disease during the study; and 4% due 
to pregnancy and moving abroad.
A previous study demonstrated that although patients with 
IBS purposely avoided certain food items that were rich in 
FODMAPs, they unknowingly maintained a high FODMAP 
intake due to the consumption of alternative FODMAP-rich 
sources (18). It has also been reported that patients with IBS 
avoid certain food items, such as milk and dairy products, 
unnecessarily, which results in a low intake of certain vitamins 
and minerals (15,16,18,20). It is therefore apparent that patients 
with IBS require guidance to appropriately manage their diet. 
The question of how dietary guidance should be provided, 
and what should it contain, remains unanswered. Individual 
guidance has been demonstrated to be effective in reducing 
the symptoms and improving the quality of life of patients with 
IBS (18), in comparison with guidance provided in a group 
situation (i.e., an IBS school), which has been demonstrated 
to be less effective (30-32). As discussed previously (20), the 
common dietary advice given to patients with IBS to reduce 
symptoms is unmanageable in daily life, and raises the risk 
of inadequate nutrient intake, particularly of vitamins and 
minerals. Dietary advice should be simple and easy to apply. 
In the present study, the patients were advised to avoid a small 
number of food items that were richest in FODMAPs and 
LQVROXEOHÀEHUVVXFKDVRQLRQVJDUOLFSDSULNDEHDQVDQG
peas. In addition, they were advised to avoid foods containing 
DUWLÀFLDOVZHHWHQHUVDQGFDUERQDWHGEHYHUDJHV
In the present study, the replacement of wheat and wheat 
products with spelt and spelt products, respectively, enabled 
the patients with IBS to continue to consume food items, such 
as bread, without a drastic change to their lifestyle. Spelt is 
known to contain fewer galactans and fructans (both of which 
are FODMAPs) than wheat. This observation challenges the 
emerging concept that gluten has a role in the development of 
symptoms in IBS (33). 
The present results demonstrate that three sessions of 
dietary guidance, each lasting 45 min and provided by a 
nurse, may reduce the symptoms and improve the quality 
of life of patients with IBS, as well improving their vitamin 
and mineral intake. This effect has been demonstrated to be 
long-term (18). This indicates that dietary guidance may be 
used as a cost-effective option for the management of IBS; 
combining dietary guidance with other lifestyle measures, 
such as a regular intake of probiotics and regular exercise, 
would augment the effect of dietary management (34). 
Food supplements with beneficial bacteria, including 
Lactobacillus spp. and %LÀGREDFWHULXPVSS., would increase 
WKHWROHUDQFHWRERWK)2'0$3VDQGÀEHUVVLQFHWKH\GRQRW
produce gas on fermenting carbohydrates (1). In addition, 
physical activity has been found to increase gastrointestinal 
transit (35,36).
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